| Literature DB >> 33471428 |
Md Rezaul Islam1, Dawid Lbik2, M Sadman Sakib1, Raoul Maximilian Hofmann2, Tea Berulava1, Martí Jiménez Mausbach1, Julia Cha1, Maria Goldberg1, Elerdashvili Vakhtang1, Christian Schiffmann1, Anke Zieseniss3,4, Dörthe Magdalena Katschinski3,4, Farahnaz Sananbenesi5, Karl Toischer2,3, Andre Fischer1,6,7.
Abstract
In current clinical practice, care of diseased patients is often restricted to separated disciplines. However, such an organ-centered approach is not always suitable. For example, cognitive dysfunction is a severe burden in heart failure patients. Moreover, these patients have an increased risk for age-associated dementias. The underlying molecular mechanisms are presently unknown, and thus, corresponding therapeutic strategies to improve cognition in heart failure patients are missing. Using mice as model organisms, we show that heart failure leads to specific changes in hippocampal gene expression, a brain region intimately linked to cognition. These changes reflect increased cellular stress pathways which eventually lead to loss of neuronal euchromatin and reduced expression of a hippocampal gene cluster essential for cognition. Consequently, mice suffering from heart failure exhibit impaired memory function. These pathological changes are ameliorated via the administration of a drug that promotes neuronal euchromatin formation. Our study provides first insight to the molecular processes by which heart failure contributes to neuronal dysfunction and point to novel therapeutic avenues to treat cognitive defects in heart failure patients.Entities:
Keywords: cognition; epigenetics; heart failure; histone; memory impairment
Year: 2021 PMID: 33471428 PMCID: PMC7933944 DOI: 10.15252/emmm.201911900
Source DB: PubMed Journal: EMBO Mol Med ISSN: 1757-4676 Impact factor: 12.137